Cencora (COR) Competitors $324.83 +5.43 (+1.70%) Closing price 10/17/2025 03:59 PM EasternExtended Trading$324.21 -0.62 (-0.19%) As of 10/17/2025 07:16 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock COR vs. ELV, MCK, CAH, HSIC, OMI, DHR, CVS, NTRA, LH, and ICLRShould you be buying Cencora stock or one of its competitors? The main competitors of Cencora include Elevance Health (ELV), McKesson (MCK), Cardinal Health (CAH), Henry Schein (HSIC), Owens & Minor (OMI), Danaher (DHR), CVS Health (CVS), Natera (NTRA), Labcorp (LH), and Icon (ICLR). These companies are all part of the "medical" sector. Cencora vs. Its Competitors Elevance Health McKesson Cardinal Health Henry Schein Owens & Minor Danaher CVS Health Natera Labcorp Icon Elevance Health (NYSE:ELV) and Cencora (NYSE:COR) are both large-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their dividends, earnings, analyst recommendations, institutional ownership, risk, media sentiment, profitability and valuation. Is ELV or COR more profitable? Elevance Health has a net margin of 2.83% compared to Cencora's net margin of 0.60%. Cencora's return on equity of 267.36% beat Elevance Health's return on equity.Company Net Margins Return on Equity Return on Assets Elevance Health2.83% 17.59% 6.36% Cencora 0.60%267.36%4.31% Does the media favor ELV or COR? In the previous week, Elevance Health had 9 more articles in the media than Cencora. MarketBeat recorded 38 mentions for Elevance Health and 29 mentions for Cencora. Cencora's average media sentiment score of 1.27 beat Elevance Health's score of 0.90 indicating that Cencora is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Elevance Health 25 Very Positive mention(s) 1 Positive mention(s) 9 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Cencora 25 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Which has more risk & volatility, ELV or COR? Elevance Health has a beta of 0.59, indicating that its share price is 41% less volatile than the S&P 500. Comparatively, Cencora has a beta of 0.63, indicating that its share price is 37% less volatile than the S&P 500. Do analysts prefer ELV or COR? Elevance Health currently has a consensus price target of $404.72, indicating a potential upside of 15.99%. Cencora has a consensus price target of $324.91, indicating a potential upside of 0.02%. Given Elevance Health's higher probable upside, analysts clearly believe Elevance Health is more favorable than Cencora.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Elevance Health 0 Sell rating(s) 10 Hold rating(s) 11 Buy rating(s) 0 Strong Buy rating(s) 2.52Cencora 0 Sell rating(s) 3 Hold rating(s) 9 Buy rating(s) 0 Strong Buy rating(s) 2.75 Do insiders & institutionals have more ownership in ELV or COR? 89.2% of Elevance Health shares are owned by institutional investors. Comparatively, 97.5% of Cencora shares are owned by institutional investors. 0.3% of Elevance Health shares are owned by insiders. Comparatively, 10.8% of Cencora shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Is ELV or COR a better dividend stock? Elevance Health pays an annual dividend of $6.84 per share and has a dividend yield of 2.0%. Cencora pays an annual dividend of $2.20 per share and has a dividend yield of 0.7%. Elevance Health pays out 29.1% of its earnings in the form of a dividend. Cencora pays out 22.6% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Elevance Health has increased its dividend for 14 consecutive years and Cencora has increased its dividend for 15 consecutive years. Which has preferable earnings & valuation, ELV or COR? Elevance Health has higher earnings, but lower revenue than Cencora. Elevance Health is trading at a lower price-to-earnings ratio than Cencora, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioElevance Health$177.01B0.44$5.98B$23.5014.85Cencora$293.96B0.21$1.51B$9.7233.42 SummaryCencora beats Elevance Health on 10 of the 19 factors compared between the two stocks. Get Cencora News Delivered to You Automatically Sign up to receive the latest news and ratings for COR and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding COR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart COR vs. The Competition Export to ExcelMetricCencoraMedical Services IndustryMedical SectorNYSE ExchangeMarket Cap$62.95B$8.41B$6.15B$21.84BDividend Yield0.68%2.14%5.72%3.62%P/E Ratio33.4254.5664.3629.73Price / Sales0.2139.58610.5760.44Price / Cash16.3321.3137.1024.21Price / Book80.406.8312.234.59Net Income$1.51B$247.60M$3.33B$1.02B7 Day Performance2.14%-0.32%1.17%1.31%1 Month Performance11.70%-4.55%6.14%-1.47%1 Year Performance36.81%4.69%59.98%9.54% Cencora Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CORCencora4.5467 of 5 stars$324.83+1.7%$324.91+0.0%+37.9%$62.95B$293.96B33.4246,000Positive NewsAnalyst ForecastELVElevance Health4.7323 of 5 stars$352.05+0.4%$411.06+16.8%-21.8%$79.20B$177.01B14.97104,200Upcoming EarningsAnalyst ForecastMCKMcKesson4.728 of 5 stars$739.04+0.1%$829.08+12.2%+55.0%$91.94B$359.05B29.4745,000Positive NewsCAHCardinal Health4.7982 of 5 stars$155.65+0.8%$166.00+6.6%+39.6%$36.98B$222.58B24.1357,700Positive NewsHSICHenry Schein4.1749 of 5 stars$65.64-2.1%$76.67+16.8%-12.1%$7.97B$12.67B21.2125,000Trending NewsAnalyst RevisionOMIOwens & Minor4.8223 of 5 stars$4.68-1.8%$7.63+63.1%-65.8%$361.87M$10.70B-0.3023,200DHRDanaher4.9653 of 5 stars$212.75-1.0%$245.91+15.6%-23.1%$152.59B$23.88B45.3463,000Trending NewsUpcoming EarningsAnalyst ForecastAnalyst RevisionCVSCVS Health4.9334 of 5 stars$77.39-0.1%$78.25+1.1%+29.8%$98.11B$386.64B21.61300,000Trending NewsAnalyst ForecastAnalyst RevisionNTRANatera2.3392 of 5 stars$169.89+1.5%$192.88+13.5%+48.5%$23.34B$1.96B-89.044,434News CoveragePositive NewsAnalyst ForecastShort Interest ↑LHLabcorp4.5524 of 5 stars$276.50-0.2%$292.00+5.6%+32.7%$22.97B$13.01B30.5170,000News CoveragePositive NewsAnalyst ForecastICLRIcon4.2359 of 5 stars$192.48-0.7%$217.33+12.9%-37.3%$15.53B$8.28B19.7841,900News CoveragePositive NewsUpcoming Earnings Related Companies and Tools Related Companies ELV Competitors MCK Competitors CAH Competitors HSIC Competitors OMI Competitors DHR Competitors CVS Competitors NTRA Competitors LH Competitors ICLR Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:COR) was last updated on 10/18/2025 by MarketBeat.com Staff From Our PartnersREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredThis dark force is about to change everythingSomething unusual is unfolding inside the Republican Party — from Marjorie Taylor Greene breaking ranks to Ted...Porter & Company | SponsoredMove $1,000 into this stock before Nov 6The End of Tesla? "Hold onto your Tesla stock." That's the message insiders at Tesla have been giving staff...Altimetry | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredThe “smart money” is piling into one AI power company.Expert Reveals: The #1 Energy Play for 2025 "We're Entering the Greatest Energy Bull Market Since the Indus...Brownstone Research | SponsoredNext opportunity for crypto millionsThe floodgates have opened. Bitcoin and Ethereum ETFs are seeing record-breaking inflows, the biggest since...Crypto 101 Media | SponsoredElon’s Optimus to mint new “Musk Millionaires” as soon as Oct 23???Elon Musk may be set to create more "Musk Millionaires" as soon as October 23rd… Because on that day, he's exp...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cencora, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cencora With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
